Category survey

The Toronto Dementia Research Alliance (TDRA) Dementia Clinical Research Database: A Platform in Neurodegenerative Diseases Investments > €500k Canada Neurodegenerative disease in general 2016    

Drug Delivery across the Human Blood-Brain Barrier Investments > €500k Canada Neurodegenerative disease in general 2016    

The role of apoE in mild traumatic brain injury Investments > €500k Canada Alzheimer’s disease & other dementias 2016    

Molecular neuroscience of Parkinson’s Disease: Retromer (VPS35) dysfunction Investments > €500k Canada Parkinson’s disease & PD-related disorders 2016    

The cellular basis of neurovascular coupling in the cerebral cortex. Investments > €500k Canada Alzheimer’s disease & other dementias 2016    

Biophysical principles of intra- and inter-molecular recognition in protein folding and interactions involving disordered proteins Investments > €500k Canada Neurodegenerative disease in general 2016    

Role of caspases in human neuronal cell death and in Alzheimer’s disease. Investments > €500k Canada Alzheimer’s disease & other dementias 2016    

Dementia Collaborative Research Centres – Carers & Consumers Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Dementia Collaborative Research Centres – Diagnosis & Prevention Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Clem Jones Centre for Ageing Dementia Research focused the on prevention and treatment of dementia Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Maintain Your Brain Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

VIND : Flemish Impulse Funding for Networks for Dementia Research Investments > €500k Belgium Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

Therapeutic target identification for FTD/ALS using human induced pluripotent stem cell models (iPSC) Investments > €500k Belgium Motor neurone diseases 2016    

MIRIAD : Molecular Imaging Research Initiative for Application in Drug Development Investments > €500k Belgium Parkinson’s disease & PD-related disorders 2016    

Biomarker based adaptive development in Alzheimer disease (BioAdaptAD) Investments > €500k Belgium Alzheimer’s disease & other dementias 2016    

Biomarker based adaptive development in Alzheimer disease (BioAdaptAD) Investments > €500k Belgium Alzheimer’s disease & other dementias 2016    

Biomarker based adaptive development in Alzheimer disease (BioAdaptAD) Investments > €500k Belgium Alzheimer’s disease & other dementias 2016    

WONDER : interventions for wandering and other behavioral disturbances of persons with dementia in residential care by personalized robot interactions Investments > €500k Belgium Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

BBB : Development of a roadmap for assessment of blood-brain barrier drug transport – Translation from rodents to patients Investments > €500k Belgium Alzheimer’s disease & other dementias 2016    

TherALS-1 : Characterisation of novel small molecule regenerative compounds for the treatment of amyotrophic lateral sclerosis Investments > €500k Belgium Motor neurone diseases 2016    

TRIAD : From pictures to numbers: adding throughput and readout to imaging in AD diagnostics Investments > €500k Belgium Alzheimer’s disease & other dementias 2016    

Canadian Centre for Aging and Brain Health Innovation Investments > €500k Canada Alzheimer’s disease & other dementias 2016    

Non Invasive Identification of Aβ Plaques in Human Retina for the Diagnosis of Alzheimer’s Disease Investments > €500k Canada Alzheimer’s disease & other dementias 2016    

Selective knockdown of misfolded SOD1 as a therapy for amyotrophic lateral sclerosis Investments > €500k Canada Motor neurone diseases 2016    

Novel MRI biomarkers for monitoring disease progression in ALS Investments > €500k Canada Motor neurone diseases 2016    

Preclinical and clinical studies with withanolides: Therapeutic effects, molecular signatures and biomarkers Investments > €500k Canada Motor neurone diseases 2016    

Discovery of Therapeutic Targets for FUS- and TDP43-Dependent Forms of ALS Investments > €500k Canada Motor neurone diseases 2016    

Restoring neuroprotective sphingosine 1-phosphate signalling in Alzheimer’s Disease Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Understanding Alzheimer’s disease using Down syndrome as a model Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

An Australian Community Of practice in Research in Dementia (ACcORD) to improve health outcomes for people with dementia and their carers Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Prevalence of Dementia in the Torres Strait and common health issues of later life in the Torres Strait Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Vascular mechanisms of neurodegeneration: drivers and determinants of dementia Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Partnership Centre: Dealing with Cognitive and Related Functional Decline in Older People Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Sleep disturbance and degeneration in Alzheimer’s disease Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Oxidant-producing proteins as novel targets to combat neurodegenerative diseases Investments > €500k Australia Neurodegenerative disease in general 2016    

Do strokes cause dementia? Brain size changes and cognition following stroke Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Preventing Falls in Older People with Dementia Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Developing insight into the molecular origins of familial and sporadic frontotemporal dementia and amyotrophic lateral sclerosis Investments > €500k Australia Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

Risk factors, early diagnosis, and effective interventions for neurocognitive disorders Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Non-Alzheimer’s disease degenerative dementias: Identifying prodromal genetic/familial phenotypes, modifying factors, and protein variations involved in progression Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Effect of an interactive therapeutic robotic animal on engagement, mood states, agitation and antispychotic drug use Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Type 2 Diabetes Mellitus and Vascular Brain Ageing Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Enhanced deep brain stimulation electrodes for improved efficacy in Parkinson’s disease therapy Investments > €500k Australia Parkinson’s disease & PD-related disorders 2016    

Targeting Post-synaptic Tau to Treat Alzheimer’s Disease Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

IRON EXPORT PROTEIN FAILURE IN PARKINSONISM AND DEMENTIA Investments > €500k Australia Alzheimer’s disease & other dementias|Parkinson’s disease & PD-related disorders 2016    

Prospective Imaging Study of Ageing: Genes, Brain & Behaviour Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Dementia Collaborative Research Centres – Assessment & Better Care Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Smart glasses: activity recognition for cognitive aid Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

Atomic details of antimicrobial peptides at work in live cells Investments > €500k Australia Alzheimer’s disease & other dementias 2016    

The amyloid beta toxic species Investments > €500k Australia Alzheimer’s disease & other dementias 2016